Why We Passionately Pursue Early Disease Detection.
Patients Win
Saves Lives
Improves Quality of Life and Patient Experiences
Protects Families from Catastrophic Outcomes
Payers Win
Lowers Cost of Care for Y1 and Beyond for Some Cancers
Increases Risk-Adjustment Revenues (RAR)
Extends Premium Payments
Providers Win
Heals Patients
Aligns with Value-Based
Care missions
Increases Shared Savings Revenue
Our Opportunity
Cancer is the leading cause of death across the globe. And, it’s growing:
2024 will be the first year that new cancer diagnoses exceed 2M in the U.S.1
Annual global cancer diagnoses are expected to rise to 29.9M by 2040.2
U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages.3
Our Mission
Together, We Can Lower Healthcare Costs and Improve Patient Outcomes:
Treating metastatic cancers can lead to 7 times higher costs than treating early-stage cancers.4
Early diagnosis across 12 solid tumor cancers could result in an estimated $26 billion cost-savings, representing about 17% of the direct costs related to cancer treatment.5
Our Opportunity
Cancer is the leading cause of death across the globe. And, it’s growing:
2024 will be the first year that new cancer diagnoses exceed 2M in the U.S.1
Annual global cancer diagnoses are expected to rise to 29.9M by 2040.2
U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages.3
Our Mission
Together, We Can Lower Healthcare Costs and Improve Patient Outcomes.
Our Team
We are a Team of Entrepreneurs, AI Engineers, Marketers, Cancer Survivors, Doctors, and Researchers.
Tom Knight
Founder & CEO
AI Healthcare Entrepreneur
Branden Lisi
Chief Patient Advocate
Stage IV Cancer Survivor | Seasoned marketer and entrepreneur focused on improving patient outcomes while lowering the cost of care.
AJ Alix
Head of Product
Serial Entrepreneur | AI Engineer
Dr. Ravi B. Parikh
Research Team
Ravi B. Parikh, MD, MPP, FACP is a medical oncologist and directs the Human-Algorithm Collaboration Lab (HACLab) at Emory University and Winship Cancer Institute, which develops scalable interventions based on advanced predictive and diagnostic algorithms to improve clinical care and health policy.
Dr. Vincent Marconi
Research Team
Director of Infectious Diseases Research at the Atlanta VA Medical Center and a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine and jointly a Professor of Global Health in the Rollins School of Public Health and the Emory Vaccine Center, Emory University.
Yan Sun, PhD
Research Team
Director of the Genetic and Molecular Epidemiology (GME) Certificate Program at Rollins School of Public Health.
Jeff Skolnick, PhD
Research Team
Regent’s Professor, Mary and Maisie Gibson Chair and GRA Eminent Scholar in Computational Systems Biology.
Sig Mosley
Board Member
Sig Mosley is the Managing Partner of Mosley Ventures, a venture fund investing in early stage technology startups in the Southeast and a Venture Partner in Zane Venture Fund. He is also an advisor to Silicon Road Ventures.
Widely regarded as “The Godfather of Angel Investing,” a title he earned as president of Imlay Investments, Inc.
Frank Wingate
Board Member
Co-founder and CEO of Industrial Computer Corporation, and more recently co-founder of LifeSpan Technologies.
Frank has a Masters Degree in electrical engineering from Stanford University.
Contact Us
Fill out the form below and we will be in touch.
Bibliography
1. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. [updated: 2024 Nov 5; cited 2025 Jan 15].
2. National Cancer Institute. Cancer Statistics. [updated 2024 May 9; cited 2024 Dec 28]. https://www.cancer.gov/about-cancer/understanding/statistics.
3. U.S. Department of Health and Human Services Public Health Service National Institutes of Health National Cancer Institute 8th Virtual Meeting Frederick National Laboratory Advisory Committee Summary of Meeting October 18, 2021.
4. Reddy SR, Broder MS, Chang E, Paydar C, Chung KC, Kansal AR. “Cost of cancer management by stage at diagnosis among Medicare beneficiaries.” Current medical research and opinion. 2022;38(8):1285–1294.
5. Zura Kakushadze, Rakesh Raghubanshi, and Willie Yu. “Estimating Cost Savings from Early Cancer Diagnosis.” Published: 4 September 2017.
Follow Our Journey
Receive updates directly to your inbox.